MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
26.76
+0.60
+2.29%
After Hours: 26.76 0 0.00% 17:01 12/05 EST
OPEN
26.43
PREV CLOSE
26.16
HIGH
26.87
LOW
25.71
VOLUME
346.92K
TURNOVER
--
52 WEEK HIGH
29.74
52 WEEK LOW
4.170
MARKET CAP
1.20B
P/E (TTM)
-17.7583
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SEPN last week (1124-1128)?
Weekly Report · 5d ago
Septerna Inc. to Present at Evercore Healthcare Conference
Reuters · 11/25 13:00
Septerna's Novo Partnership Begins To Transform The Story
Seeking Alpha · 11/25 07:58
Weekly Report: what happened at SEPN last week (1117-1121)?
Weekly Report · 11/24 09:48
Cantor Fitzgerald Sticks to Their Buy Rating for Septerna, Inc. (SEPN)
TipRanks · 11/21 13:36
Septerna price target raised to $34 from $28 at JPMorgan
TipRanks · 11/18 12:35
SEPTERNA INC <SEPN.O>: JP MORGAN RAISES TARGET PRICE TO $34 FROM $28
Reuters · 11/18 10:19
U.S. RESEARCH ROUNDUP- Autodesk, Crowdstrike, Zscaler
Reuters · 11/18 07:40
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.